Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...